Bionerics Research owns a proprietary procedure, which can successfully predict the behaviour of novel drug candidates against key human proteins related to a wide range of pathologies. According to all experts, this faculty is an essential and very advantageous step when designing new drugs.

Bionerics Research will design, synthesize and carry out all the preclinical experimentation of its products to guarantee the quality and protocol of the compounds before offering them as innovative licenses to pharmaceutical customers.

Bionerics Research places great emphasis in having intense and dynamic commercial and marketing activities combined with top-level scientific work. Our organisation is based on the model of a “drug discovery company”. We have  prepared a solid financial plan based on the licensing of our products.

Bionerics Research can also take the most of its own technology to monitor the activity of existing drugs and offer alternative strategies for them.

All Bionerics licenses are meant to be protected under patents.

Bionerics Research is in funding round with interesting and successful expectations.